News

Lonza recently announced a significant enhancement to its powder characterization capabilities at its Small Molecules site in Tampa, Florida, US. The facility has been upgraded to include universal powder flow testing alongside automated particle size and shape analysis capabilities....

Sandoz, a global leader in generic and biosimilar medicines, signed a Memorandum of Understanding (MoU) to build a new biologics production plant in Lendava, Slovenia. The Sandoz investment is expected to be at least USD 400 million, supporting the company’s...

Shuttle Pharmaceuticals Holdings, Inc., a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced it has signed an agreement with the University of Iowa (UI) Pharmaceuticals...

Simris Alg AB, a European biologics company focused on extracting high value biological active compounds from microalgae and cyanobacteria, announced a framework collaboration agreement with Lonza Ltd, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, to commercialize...

A new approach that has been created at the Medical University of South Carolina that specifically aims at enhancing clinical trial eligibility has shown positive results. The patient outreach recruitment team that has been floated by the South Carolina Clinical...

Nurses have long been regarded as agents of change in their communities, playing a critical role in ensuring public health and educating individuals on the importance of preventive care. As healthcare professionals, nurses are uniquely positioned to create and...

Researchers from the University of East Anglia- UEA have come up with a new non-invasive treatment for bone cancer that happens to be effective against all primary forms of the disease. Notably, the current bone cancer treatment remains invasive...